A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes

Clinical trial NCT01511900 · COMPLETED

Trial details

NCT number: NCT01511900
Sponsor: Catabasis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2011-12-01
Primary completion: 2012-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.